IFNA1 and COVID-19: Because no serum samples were available from the fatal cases, we cross-examined our fatal COVID-19 immune gene signature with the LAIR1 biomarker recently described by van der Wijst et al.33 as strongly correlated to anti-IFN auto-antibodies.